Last updated at 24 Sep 2024 03:40 AM
Director
DIN: 09354994
Yogabhishek Kambam is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at ALLELE LABORATORIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09354994.Yogabhishek Kambam has previously been associated with 1 company in roles such as Designated Partner.Yogabhishek Kambam is currently involved in 2 different roles. Their most recent position is with EVOLVIN BIOPHARMA LLP as a Designated Partner. The first company Yogabhishek Kambam was appointed to as a director was ALLELE LABORATORIES PRIVATE LIMITED. Yogabhishek Kambam is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Yogabhishek Kambam is currently associated with 2 companies in various capacities such as Director and Designated Partner. They serve as a Director at ALLELE LABORATORIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09354994.Yogabhishek Kambam has previously been associated with 1 company in roles such as Designated Partner.Yogabhishek Kambam is currently involved in 2 different roles. Their most recent position is with EVOLVIN BIOPHARMA LLP as a Designated Partner. The first company Yogabhishek Kambam was appointed to as a director was ALLELE LABORATORIES PRIVATE LIMITED. Yogabhishek Kambam is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Male
India
Gain instant access to verified contact details.
Current Companies (1)
Current LLPs (1)
Past Companies (1)
10 Months 5 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ALLELE LABORATORIES PRIVATE LIMITED | Director | 08-Dec-2021 |